Screening compound: NYZQPCIJFHVZCC-UHFFFAOYSA-N

Screening compound: NYZQPCIJFHVZCC-UHFFFAOYSA-N
Screening compound: NYZQPCIJFHVZCC-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
NYZQPCIJFHVZCC-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K405-4324

Molecular Formula

C19H22N6O (C19 H22 N6 O)

Compound Name

1-[1-(3,5-dimethylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]piperidine-4-carboxamide

IUPAC name

1-[1-(35-dimethylphenyl)-1H-pyrazolo[34-d]pyrimidin-4-yl]piperidine-4-carboxamide

SMILES

Cc1cc(-n2ncc3c2ncnc3N(CC2)CCC2C(N)=O)cc(C)c1

InChI

InChI=1S/C19H22N6O/c1-12-7-13(2)9-15(8-12)25-19-16(10-23-25)18(21-11-22-19)24-5-3-14(4-6-24)17(20)26/h7-11,14H,3-6H2,1-2H3,(H2,20,26)

InChI Key

NYZQPCIJFHVZCC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08535255

NYZQPCIJFHVZCC-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Peptidomimetic Library (37031 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Kinases
  • GPCR
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with NYZQPCIJFHVZCC-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound NYZQPCIJFHVZCC-UHFFFAOYSA-N?
Check Price and Availability of NYZQPCIJFHVZCC-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of NYZQPCIJFHVZCC-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for NYZQPCIJFHVZCC-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for NYZQPCIJFHVZCC-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of NYZQPCIJFHVZCC-UHFFFAOYSA-N available by request